Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. Zhang F, Tang X, Fan S, Liu X, et al. Oncogene 2021 May 20. pii: 10.1038/s41388-021-01834.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang F, Tang X, Fan S, Liu X, et al. Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. Oncogene 2021 May 20. pii: 10.1038/s41388-021-01834.
PMID: 34017080